Skip to content

To find out Effect of Raktapradarahara choorna in asrigdara

AN OPEN LABEL RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFECT OF RAKTAPRADARAHARA CHOORNA IN ASRIGDHARA VIS-À-VIS ABNORMAL UTERINE BLEEDING - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072974
Enrollment
40
Registered
2024-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

None listed

Sponsors

Dr Chandarani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects fulfilling Diagnostic Criteria Subjects with H/O excessive bleeding during menstruation subjects with HB below 10gm

Exclusion criteria

Exclusion criteria: Subjects with IUCD, Contraceptive pills, pelvic pathology, endometriosis, PID, adenomyosis, Chronic cervicitis, Benign and malignant growth in reproductive organs, miscarriage bleeding followed by active abortion, coagulation disorders

Design outcomes

Primary

MeasureTime frame
bleeding will be controlledTimepoint: 3 months of continuos use will help in controlling heavy bleeding

Secondary

MeasureTime frame
loss of blood due to heavy cycles leads to anemia, which can be preventedTimepoint: 3 months regular use

Countries

India

Contacts

Public ContactDr Seemantini Dundappa Yalagudri

JSS Ayurveda Medical College and Hospital

seemantinij@gmail.com7349496230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026